Atlas Trials

A Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolite Profile and Metabolite Identification of [14C]AZD4831

Clinical trial NCT04407091 · COMPLETED

Trial details

NCT number
NCT04407091
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cardiovascular Disease
Start date
2020-06-30
Primary completion
2020-08-06
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.